Erlotinib dosing in lung cancer depends on smoking status
Links shared publicly online about this topic.
- 1,460total visits
Erlotinib dosing in lung cancer depends on smoking status
Although erlotinib is an approved second-line therapy for lung cancer, its management is complicated by side effects that get worse as the dose increases.
View full resource at physorg.com
Tags: Cancer, Lung Cancer, Non-Small Cell Lung Cancer Medication, Lung, Smoking Cessation, Tarceva
Most Recently Shared on January 13, 2010 at 4:59 am By:
Erlotinib dosing in lung cancer depends on smoking status http://bit.ly/8jiNJP
Erlotinib Dosing In Lung Cancer Depends On Smoking Status
medicalnewstoday.com — “Although erlotinib is an approved second-line therapy for lung cancer, its management is complicated by side effects that get worse as the dose increases. increased doses may lead to bet” View full resource at medicalnewstoday.com
Most Recently Shared on January 14, 2010 at 1:06 am By:
Erlotinib Dosing In Lung Cancer Depends On Smoking Status http://mnt.to/3wfm
Advertisement
